Cargando…

High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples

In late 2019, a novel coronavirus began spreading in Wuhan, China, causing a potentially lethal respiratory viral infection. By early 2020, the novel coronavirus, called SARS-CoV-2, had spread globally, causing the COVID-19 pandemic. The infection and mutation rates of SARS-CoV-2 make it amenable to...

Descripción completa

Detalles Bibliográficos
Autores principales: Pater, Adrian A., Bosmeny, Michael S., White, Adam A., Sylvain, Rourke J., Eddington, Seth B., Parasrampuria, Mansi, Ovington, Katy N., Metz, Paige E., Yinusa, Abadat O., Barkau, Christopher L., Chilamkurthy, Ramadevi, Benzinger, Scott W., Hebert, Madison. M., Gagnon, Keith T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Biological Methods 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493558/
https://www.ncbi.nlm.nih.gov/pubmed/34631911
http://dx.doi.org/10.14440/jbm.2021.360
_version_ 1784579137535475712
author Pater, Adrian A.
Bosmeny, Michael S.
White, Adam A.
Sylvain, Rourke J.
Eddington, Seth B.
Parasrampuria, Mansi
Ovington, Katy N.
Metz, Paige E.
Yinusa, Abadat O.
Barkau, Christopher L.
Chilamkurthy, Ramadevi
Benzinger, Scott W.
Hebert, Madison. M.
Gagnon, Keith T.
author_facet Pater, Adrian A.
Bosmeny, Michael S.
White, Adam A.
Sylvain, Rourke J.
Eddington, Seth B.
Parasrampuria, Mansi
Ovington, Katy N.
Metz, Paige E.
Yinusa, Abadat O.
Barkau, Christopher L.
Chilamkurthy, Ramadevi
Benzinger, Scott W.
Hebert, Madison. M.
Gagnon, Keith T.
author_sort Pater, Adrian A.
collection PubMed
description In late 2019, a novel coronavirus began spreading in Wuhan, China, causing a potentially lethal respiratory viral infection. By early 2020, the novel coronavirus, called SARS-CoV-2, had spread globally, causing the COVID-19 pandemic. The infection and mutation rates of SARS-CoV-2 make it amenable to tracking introduction, spread and evolution by viral genome sequencing. Efforts to develop effective public health policies, therapeutics, or vaccines to treat or prevent COVID-19 are also expected to benefit from tracking mutations of the SARS-CoV-2 virus. Here we describe a set of comprehensive working protocols, from viral RNA extraction to analysis using established visualization tools, for high throughput sequencing of SARS-CoV-2 viral genomes using a MinION instrument. This set of protocols should serve as a reliable “how-to” reference for generating quality SARS-CoV-2 genome sequences with ARTIC primer sets and long-read nanopore sequencing technology. In addition, many of the preparation, quality control, and analysis steps will be generally applicable to other sequencing platforms.
format Online
Article
Text
id pubmed-8493558
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Journal of Biological Methods
record_format MEDLINE/PubMed
spelling pubmed-84935582021-10-07 High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples Pater, Adrian A. Bosmeny, Michael S. White, Adam A. Sylvain, Rourke J. Eddington, Seth B. Parasrampuria, Mansi Ovington, Katy N. Metz, Paige E. Yinusa, Abadat O. Barkau, Christopher L. Chilamkurthy, Ramadevi Benzinger, Scott W. Hebert, Madison. M. Gagnon, Keith T. J Biol Methods Article In late 2019, a novel coronavirus began spreading in Wuhan, China, causing a potentially lethal respiratory viral infection. By early 2020, the novel coronavirus, called SARS-CoV-2, had spread globally, causing the COVID-19 pandemic. The infection and mutation rates of SARS-CoV-2 make it amenable to tracking introduction, spread and evolution by viral genome sequencing. Efforts to develop effective public health policies, therapeutics, or vaccines to treat or prevent COVID-19 are also expected to benefit from tracking mutations of the SARS-CoV-2 virus. Here we describe a set of comprehensive working protocols, from viral RNA extraction to analysis using established visualization tools, for high throughput sequencing of SARS-CoV-2 viral genomes using a MinION instrument. This set of protocols should serve as a reliable “how-to” reference for generating quality SARS-CoV-2 genome sequences with ARTIC primer sets and long-read nanopore sequencing technology. In addition, many of the preparation, quality control, and analysis steps will be generally applicable to other sequencing platforms. Journal of Biological Methods 2021-09-27 /pmc/articles/PMC8493558/ /pubmed/34631911 http://dx.doi.org/10.14440/jbm.2021.360 Text en © 2013-2021 The Journal of Biological Methods, All rights reserved. https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License: http://creativecommons.org/licenses/by-nc-sa/4.0
spellingShingle Article
Pater, Adrian A.
Bosmeny, Michael S.
White, Adam A.
Sylvain, Rourke J.
Eddington, Seth B.
Parasrampuria, Mansi
Ovington, Katy N.
Metz, Paige E.
Yinusa, Abadat O.
Barkau, Christopher L.
Chilamkurthy, Ramadevi
Benzinger, Scott W.
Hebert, Madison. M.
Gagnon, Keith T.
High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples
title High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples
title_full High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples
title_fullStr High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples
title_full_unstemmed High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples
title_short High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples
title_sort high throughput nanopore sequencing of sars-cov-2 viral genomes from patient samples
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493558/
https://www.ncbi.nlm.nih.gov/pubmed/34631911
http://dx.doi.org/10.14440/jbm.2021.360
work_keys_str_mv AT pateradriana highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples
AT bosmenymichaels highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples
AT whiteadama highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples
AT sylvainrourkej highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples
AT eddingtonsethb highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples
AT parasrampuriamansi highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples
AT ovingtonkatyn highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples
AT metzpaigee highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples
AT yinusaabadato highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples
AT barkauchristopherl highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples
AT chilamkurthyramadevi highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples
AT benzingerscottw highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples
AT hebertmadisonm highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples
AT gagnonkeitht highthroughputnanoporesequencingofsarscov2viralgenomesfrompatientsamples